RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.
RB1-inducible coiled-coil 1 (RB1CC1, also known as FIP200) plays a role in the enhancement of the RB1 pathway through the direct binding to a GC-rich region 201bp upstream (from the initiation ATG) of the RB1 promoter. Here, we identified hSNF5 and p53 as the binding partners of RB1CC1 by immunoprec...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2010
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/05129a21b0584f3c8421d519a11d14ce |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:05129a21b0584f3c8421d519a11d14ce |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:05129a21b0584f3c8421d519a11d14ce2021-12-02T20:20:21ZRB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.1932-620310.1371/journal.pone.0011404https://doaj.org/article/05129a21b0584f3c8421d519a11d14ce2010-06-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20614030/?tool=EBIhttps://doaj.org/toc/1932-6203RB1-inducible coiled-coil 1 (RB1CC1, also known as FIP200) plays a role in the enhancement of the RB1 pathway through the direct binding to a GC-rich region 201bp upstream (from the initiation ATG) of the RB1 promoter. Here, we identified hSNF5 and p53 as the binding partners of RB1CC1 by immunoprecipitation and immunofluorescence assays. Interaction between these molecules and the RB1 pathway was analyzed by the assays of chromatin immunoprecipitation, luciferase-reporter, reverse transcription-polymerase chain reaction and immunoblot. The tumor growth suppression by RB1CC1 was evaluated by flow cytometry or by a cell growth assay. The nuclear RB1CC1 complex involving hSNF5 and/or p53 activated transcription of RB1, p16 and p21, and suppressed tumor cell growth. Furthermore, nuclear RB1CC1 expression significantly correlated with those of RB1 and p16 in breast cancer tissue in vivo, and the Ki-67 proliferation index was dependent on p53 as well as RB1CC1. The present study indicates that RB1CC1 together with hSNF5 and/or p53 enhances the RB1 pathway through transcriptional activation of RB1, p16 and p21. Evaluation of RB1CC1 expression combined with RB1 and p53 status is expected to provide useful information in clinical practice and future therapeutic strategies in breast cancer.Tokuhiro ChanoKaichiro IkebuchiYasuko OchiHitosuke TamenoYasuhiko TomitaYufen JinHideo InajiMakoto IshitobiKoji TeramotoIchiro NishimuraKahori MinamiHirokazu InoueTakahiro IsonoMasao SaitohTaketoshi ShimadaYasuo HisaHidetoshi OkabePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 6, p e11404 (2010) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Tokuhiro Chano Kaichiro Ikebuchi Yasuko Ochi Hitosuke Tameno Yasuhiko Tomita Yufen Jin Hideo Inaji Makoto Ishitobi Koji Teramoto Ichiro Nishimura Kahori Minami Hirokazu Inoue Takahiro Isono Masao Saitoh Taketoshi Shimada Yasuo Hisa Hidetoshi Okabe RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| description |
RB1-inducible coiled-coil 1 (RB1CC1, also known as FIP200) plays a role in the enhancement of the RB1 pathway through the direct binding to a GC-rich region 201bp upstream (from the initiation ATG) of the RB1 promoter. Here, we identified hSNF5 and p53 as the binding partners of RB1CC1 by immunoprecipitation and immunofluorescence assays. Interaction between these molecules and the RB1 pathway was analyzed by the assays of chromatin immunoprecipitation, luciferase-reporter, reverse transcription-polymerase chain reaction and immunoblot. The tumor growth suppression by RB1CC1 was evaluated by flow cytometry or by a cell growth assay. The nuclear RB1CC1 complex involving hSNF5 and/or p53 activated transcription of RB1, p16 and p21, and suppressed tumor cell growth. Furthermore, nuclear RB1CC1 expression significantly correlated with those of RB1 and p16 in breast cancer tissue in vivo, and the Ki-67 proliferation index was dependent on p53 as well as RB1CC1. The present study indicates that RB1CC1 together with hSNF5 and/or p53 enhances the RB1 pathway through transcriptional activation of RB1, p16 and p21. Evaluation of RB1CC1 expression combined with RB1 and p53 status is expected to provide useful information in clinical practice and future therapeutic strategies in breast cancer. |
| format |
article |
| author |
Tokuhiro Chano Kaichiro Ikebuchi Yasuko Ochi Hitosuke Tameno Yasuhiko Tomita Yufen Jin Hideo Inaji Makoto Ishitobi Koji Teramoto Ichiro Nishimura Kahori Minami Hirokazu Inoue Takahiro Isono Masao Saitoh Taketoshi Shimada Yasuo Hisa Hidetoshi Okabe |
| author_facet |
Tokuhiro Chano Kaichiro Ikebuchi Yasuko Ochi Hitosuke Tameno Yasuhiko Tomita Yufen Jin Hideo Inaji Makoto Ishitobi Koji Teramoto Ichiro Nishimura Kahori Minami Hirokazu Inoue Takahiro Isono Masao Saitoh Taketoshi Shimada Yasuo Hisa Hidetoshi Okabe |
| author_sort |
Tokuhiro Chano |
| title |
RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| title_short |
RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| title_full |
RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| title_fullStr |
RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| title_full_unstemmed |
RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| title_sort |
rb1cc1 activates rb1 pathway and inhibits proliferation and cologenic survival in human cancer. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2010 |
| url |
https://doaj.org/article/05129a21b0584f3c8421d519a11d14ce |
| work_keys_str_mv |
AT tokuhirochano rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT kaichiroikebuchi rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT yasukoochi rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT hitosuketameno rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT yasuhikotomita rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT yufenjin rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT hideoinaji rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT makotoishitobi rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT kojiteramoto rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT ichironishimura rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT kahoriminami rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT hirokazuinoue rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT takahiroisono rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT masaosaitoh rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT taketoshishimada rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT yasuohisa rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer AT hidetoshiokabe rb1cc1activatesrb1pathwayandinhibitsproliferationandcologenicsurvivalinhumancancer |
| _version_ |
1718374147507093504 |